Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of TransCode Therapeutics Inc (NASDAQ: RNAZ) was $0.27 for the day, up 6.64% from the previous closing price of $0.25. In other words, the price has increased by $6.64 from its previous closing price. On the day, 0.99 million shares were traded. RNAZ stock price reached its highest trading level at $0.274 during the session, while it also had its lowest trading level at $0.2416.
Ratios:
Our analysis of RNAZ’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 1.25 and its Current Ratio is at 1.25. In the meantime, Its Debt-to-Equity ratio is 0.17 whereas as Long-Term Debt/Eq ratio is at 0.00.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Sep 28 ’23 when Fitzgerald Thomas A bought 49,350 shares for $0.51 per share. The transaction valued at 25,168 led to the insider holds 56,318 shares of the business.
Dudley Robert Michael bought 98,000 shares of RNAZ for $49,980 on Sep 28 ’23. The Chief Executive Officer now owns 180,262 shares after completing the transaction at $0.51 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RNAZ now has a Market Capitalization of 4603036 and an Enterprise Value of 1475719.
Stock Price History:
Over the past 52 weeks, RNAZ has reached a high of $128.00, while it has fallen to a 52-week low of $0.22. The 50-Day Moving Average of the stock is -63.88%, while the 200-Day Moving Average is calculated to be -91.08%.
Shares Statistics:
RNAZ traded an average of 1.13M shares per day over the past three months and 586090 shares per day over the past ten days. A total of 17.27M shares are outstanding, with a floating share count of 17.23M. Insiders hold about 0.19% of the company’s shares, while institutions hold 11.46% stake in the company. Shares short for RNAZ as of 1722384000 were 1635985 with a Short Ratio of 1.45, compared to 1719532800 on 167182. Therefore, it implies a Short% of Shares Outstanding of 1635985 and a Short% of Float of 9.4799995.
